이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Jaguar Health 관리
관리 기준 확인 4/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Lisa Conte
최고 경영자
US$815.9k
총 보상
| CEO 급여 비율 | 70.6% |
| CEO 임기 | 11yrs |
| CEO 소유권 | 0.002% |
| 경영진 평균 재임 기간 | 3.5yrs |
| 이사회 평균 재임 기간 | 6.3yrs |
최근 관리 업데이트
Recent updates
Jaguar Health, Inc. (NASDAQ:JAGX) Might Not Be As Mispriced As It Looks After Plunging 49%
May 24
Jaguar Health, Inc. (NASDAQ:JAGX) Shares Fly 55% But Investors Aren't Buying For Growth
Mar 29Jaguar Health, Inc. (NASDAQ:JAGX) Not Doing Enough For Some Investors As Its Shares Slump 39%
Jan 22Positive Sentiment Still Eludes Jaguar Health, Inc. (NASDAQ:JAGX) Following 32% Share Price Slump
Jun 10Jaguar Health (NASDAQ:JAGX) Is Carrying A Fair Bit Of Debt
Jan 23Jaguar Health rises 19% on orphan drug tag for congenital diarrheal disorder treatment
Oct 17Jaguar Health sells crofelemer and lechlemer royalty rights for $4M upfront
Aug 25Jaguar Health gets 180-day grace period to regain compliance with Nasdaq's listing rule
Aug 19Jaguar Health rises on U.S. patent for treating chemotherapy-induced diarrhea
Aug 09Jaguar stock rises on license deal with SynWorld for Canalevia in China
Jun 29Jaguar Health CEO Lisa Conte - From Rainforest To Laboratory
Mar 07Jaguar Health shares jumps 13% after pricing $15M direct offering
Jan 13Jaguar Health plans for conditional marketing application in Europe for Crofelemer, initially for Long-Hauler COVID-19 patients
Jan 11Jaguar Health leaps higher in new year
Jan 05Jaguar Health inks second Mytesi royalties agreement for $6M
Dec 23Does Jaguar Health (NASDAQ:JAGX) Have A Healthy Balance Sheet?
Dec 02
Jaguar Health's crofelemer development nears SPAC funding in Europe, shares +61%
Nov 30Jaguar Health EPS misses by $0.10, misses on revenue
Nov 16Jaguar Health receives positive Nasdaq listing determination
Oct 29CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$38m |
| Dec 31 2023 | US$816k | US$576k | -US$41m |
| Sep 30 2023 | n/a | n/a | -US$40m |
| Jun 30 2023 | n/a | n/a | -US$44m |
| Mar 31 2023 | n/a | n/a | -US$42m |
| Dec 31 2022 | US$1m | US$603k | -US$47m |
| Sep 30 2022 | n/a | n/a | -US$54m |
| Jun 30 2022 | n/a | n/a | -US$54m |
| Mar 31 2022 | n/a | n/a | -US$59m |
| Dec 31 2021 | US$3m | US$527k | -US$53m |
| Sep 30 2021 | n/a | n/a | -US$50m |
| Jun 30 2021 | n/a | n/a | -US$46m |
| Mar 31 2021 | n/a | n/a | -US$42m |
| Dec 31 2020 | US$1m | US$500k | -US$39m |
| Sep 30 2020 | n/a | n/a | -US$35m |
| Jun 30 2020 | n/a | n/a | -US$39m |
| Mar 31 2020 | n/a | n/a | -US$45m |
| Dec 31 2019 | US$1m | US$500k | -US$45m |
| Sep 30 2019 | n/a | n/a | -US$48m |
| Jun 30 2019 | n/a | n/a | -US$43m |
| Mar 31 2019 | n/a | n/a | -US$34m |
| Dec 31 2018 | US$1m | US$480k | -US$32m |
| Sep 30 2018 | n/a | n/a | -US$41m |
| Jun 30 2018 | n/a | n/a | -US$30m |
| Mar 31 2018 | n/a | n/a | -US$24m |
| Dec 31 2017 | US$643k | US$440k | -US$22m |
보상 대 시장: Lisa 의 총 보상 ($USD 815.85K )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 683.56K ).
보상과 수익: Lisa 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Lisa Conte (65 yo)
11yrs
테뉴어
US$815,854
보상
Ms. Lisa A. Conte serves as a Scientific Advisor at Triton Funds LLC. She is a Former Member of Scientific Advisory Board at Triton Funds LLC. She founded Jaguar Health, Inc. (formerly known as Jaguar Anim...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Founder | 11yrs | US$815.85k | 0.0023% $ 485.7 | |
| Chief Scientific Officer & Chair of Scientific Advisory Board | 2.3yrs | US$627.13k | 0.00068% $ 143.0 | |
| Chief of Staff | 5.6yrs | US$562.79k | 0.00064% $ 134.6 | |
| Chief of Sustainable Supply | 9.8yrs | US$491.54k | 0.00055% $ 115.6 | |
| Chief Financial Officer | 4.3yrs | 데이터 없음 | 0.00036% $ 75.7 | |
| Senior Director of Investor Relations | no data | 데이터 없음 | 데이터 없음 | |
| Executive VP of Corporate & Business Development | 2.8yrs | 데이터 없음 | 데이터 없음 | |
| Chief Manufacturing Officer | no data | 데이터 없음 | 데이터 없음 | |
| Chief Commercial Officer | 3.5yrs | US$557.90k | 0% $ 0 | |
| President of Jaguar International | less than a year | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Growth Strategy | less than a year | 데이터 없음 | 데이터 없음 |
3.5yrs
평균 재임 기간
63.5yo
평균 연령
경험이 풍부한 관리: JAGX 의 관리팀은 경험 ( 3.5 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Founder | 11yrs | US$815.85k | 0.0023% $ 485.7 | |
| Chief Scientific Officer & Chair of Scientific Advisory Board | 7.1yrs | US$627.13k | 0.00068% $ 143.0 | |
| Independent Chairman | 10.3yrs | US$140.98k | 0.00072% $ 151.4 | |
| Independent Director | 8.2yrs | US$101.68k | 0.00042% $ 88.3 | |
| Independent Director | 1.9yrs | US$77.61k | 0.00055% $ 115.6 | |
| Independent Director | 6.3yrs | US$104.18k | 0.00045% $ 94.6 | |
| Member of Scientific Advisory Board | 1.4yrs | 데이터 없음 | 데이터 없음 | |
| Scientific Advisory Board | 1.3yrs | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | 1.1yrs | 데이터 없음 | 데이터 없음 |
6.3yrs
평균 재임 기간
66yo
평균 연령
경험이 풍부한 이사회: JAGX 의 이사회는 경험(평균 재직 기간 6.3 년)으로 간주됩니다.